Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 28, 1994 - Issue 1
Submit an article Journal homepage
28
Views
51
CrossRef citations to date
0
Altmetric
Original Article

29-Week Doxazosin Treatment in Patients with Symptomatic Benign Prostatic Hyperplasia

A Double-Blind Placebo-Controlled Study

Jørgen Bendix HolmeDepartment of Surgery K, Skejby Hospital, University Hospital of Aarhus, Denmark
,
Mads Mark ChristensenFrom the Department of Surgery K and Clinical Physiological Department, Randers Central Hospital
,
Peter Christian RasmussenFrom the Department of Surgery K and Clinical Physiological Department, Randers Central Hospital
,
Flemming JacobsenDepartment of Surgery K, Skejby Hospital, University Hospital of Aarhus, Denmark
,
Jørn NielsenFrom the Department of Surgery K and Clinical Physiological Department, Randers Central Hospital
,
Jens Peter NørgaardDepartment of Surgery K, Skejby Hospital, University Hospital of Aarhus, Denmark
,
Sigurd OlesenFrom the Department of Surgery K and Clinical Physiological Department, Randers Central Hospital
,
Ivan NoerDepartment of Surgery K, Skejby Hospital, University Hospital of Aarhus, Denmark
,
Hans WolfDepartment of Surgery K, Skejby Hospital, University Hospital of Aarhus, Denmark
&
Steen Elkjær HustedDepartment of Surgery K, Skejby Hospital, University Hospital of Aarhus, Denmark
 show all
Pages 77-82 | Received 30 Dec 1992, Accepted 25 May 1993, Published online: 15 Feb 2010

REFERENCES

  • Caine M, Raz S, Zeigler M. Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Br J Urol 1975; 47: 193–202.
  • Hedlund H, Andersson K-E, Larsson B. Alpha-adrenoceptors and muscarinic receptors in the isolated human prostate. J Urol 1985; 134: 1291–1298.
  • Caine M. The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy. J Urol 1986; 136: 1–4.
  • Caine M. Alpha-adrenergic blockers for the treatment of benign prostatic hyperplasia. Urol Clin N Am 1991; 17: 641–649.
  • Hedlund H, Andersson K-E, Ek A. Effects of prazosin in patients with benign prostatic obstruction. J Urol 1983; 130: 275–278.
  • Martorana G, Giberti C, Damonte P, Ciprandi G, Dirienzo W, Giuliani L. The effect of prazosin in benign prostatic hypertrophy, a placebo-controlled double-blind study. IRCS Med Sci 1984; 12: 11–12.
  • Kirby RS, Coppinger SWC, Corcoran MO, Chapple CR, Flannigan M, Milroy EJG. Prazosin in the treatment of prostatic obstruction. A placebo-controlled study. Br J Urol 1987; 60: 136–142.
  • Chappie CR, Christmas TJ, Milry EJG. A twelve-week placebo-controlled study of prazosin in the treatment of prostatic obstruction. Urol Int 1990; 45 (Suppl): 47–55.
  • Le Duc A, Cariou G, Baron C, Cukier J, Quentel P, Faure G, Rambeaud JJ, Navratil H, Costa P, Richaud JJ, Henry JC, Lardennois B, Verges J. A multicenter, double-blind, placebo-controlled trial of the efficacy of prazosin in the treatment of dysuria associated with benign prostatic hypertrophy. Urol Int 1990; 45 (Suppl): 56–62.
  • Sertcelik MN, Unal S, Ozgur S, Imamoglu A. Prazosin, a selective alpha1 receptor blocker, in the treatment of benign prostatic hypertrophy. Curr Ther Res 1990; 48: 1066–1074.
  • Christensen MM, Holme JB, Rasmussen PC, Jacobsen F, Nielsen J, Nôrgaard JP, Olesen S, Noer I, Wolf H, Husted SE. Doxazosin in shortterm treatment of prostatic obstruction: A double-blind placebo-controlled study. Scand J Urol Nephrol 1993; 27: 39–44.
  • Taylor SH. Pharmacotherapeutic stature of doxazosin and its role in coronary risk reduction. Am Heart J 1988; 116: 1735–1747.
  • Jardin A, Bensadoun H, Delauche-Cavallier M, Attali P and The BPH-ALF-group. Alfuzosin for treatment of benign prostatic hypertrophy. The Lancet 1991; 337: 1457–1461.
  • Bruskewitz RC, Iversen P, Madsen PO. Value of postvoid residual urine determination in evaluation of prostatism. Urology 1982; 20: 602–604.
  • Birch NC, Hurst G, Doyle PT. Serial residual volumes In men with prostatic hypertrophy. Br J Urol 1988; 62: 571–575.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.